11:47 AM EST - Amorfix Life Sciences Ltd. : announced today that the Company is collaborating with Dr. Dawn Waterhouse from the B.C. Cancer Agency and the University of British Columbia to test the Company's tumor specific antibodies in animal models of ovarian cancer. Amorfix Life Sciences Ltd.
shares T.AMF are trading up $0.01 at $0.44.
